Evoke Pharma, Inc. (EVOK)

Evoke Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	4.74	9.84	9.14	8.07	5.66
Cash & Cash Equivalents	4.74	9.84	9.14	8.07	5.66
Cash Growth	-51.85%	7.64%	13.33%	42.46%	6.48%
Receivables	0.67	0.62	0.3	0.02	0
Inventory	0.48	0.29	0.19	0.24	0
Other Current Assets	0.93	0.96	0.94	0.95	0.58
Total Current Assets	6.83	11.72	10.56	9.28	6.25
Property, Plant & Equipment	0	0.13	0.01	0.14	0.14
Other Long-Term Assets	0.24	0	0	0.01	0.01
Total Long-Term Assets	0.24	0.13	0.01	0.15	0.15
Total Assets	7.07	11.85	10.57	9.43	6.4
Accounts Payable	1.71	0.93	0.87	6.27	1.03
Current Debt	5	0.13	0.01	0.25	0.14
Other Current Liabilities	2.94	0.59	0.52	1.02	0.84
Total Current Liabilities	9.65	1.65	1.41	7.54	2.02
Long-Term Debt	0	5	5	5	0
Other Long-Term Liabilities	0	1.11	0.61	0.11	0
Total Long-Term Liabilities	0	6.11	5.61	5.11	0
Total Liabilities	9.65	7.77	7.02	12.65	2.02
Total Debt	5	5.13	5.01	5.25	0.14
Debt Growth	-2.52%	2.33%	-4.45%	3686.60%	-
Retained Earnings	-123.44	-115.65	-107.42	-98.89	-85.73
Shareholders' Equity	-2.58	4.08	3.56	-3.21	4.38
Net Cash / Debt	-0.26	4.71	4.13	2.82	5.53
Net Cash / Debt Growth	-	14.09%	46.38%	-48.91%	3.88%
Net Cash Per Share	-0.08	1.50	1.54	1.33	2.97
Working Capital	-2.82	10.07	9.15	1.75	4.23
Book Value Per Share	-0.77	1.30	1.32	-1.51	2.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).